The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
A 15-mg dose with a corticosteroid taper regimen was superior to placebo in sustained remission from week 12 to 52.
Statement by Chip Davis, President and CEO, GPhA, Regarding the State of the Union Address
January 14th 2016In the State of the Union address, President Barack Obama called for a major new initiative to identify a cure for cancer. GPhA applauds this administration's efforts to fight cancer by funding the research that we all hope leads to a cure.
Read More
Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia
January 13th 2016oehringer Ingelheim and Arena Pharmaceuticals have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor, which belongs to the group of orphan CNS receptors.
Read More